Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

View source ↗

Summary

The BioHOBIT trial is evaluating biomarkers in hyperbaric oxygen therapy for traumatic brain injury and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Traumatic Brain Injury | Status: RECRUITING